| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 18,275 | 21,216 | 15,740 | 22,315 | | Cost of Revenue | 12,777 | 13,035 | 9,265 | 12,990 | | | Gross Profit | 5,498 | 8,180 | 6,475 | 9,325 | | | Operating Expenses | | Research Development | 2,115 | 1,851 | 1,813 | 1,656 | | Selling General and Administrative | 6,086 | 6,086 | 5,565 | 5,715 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,703) | 243 | (903) | 1,954 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 110 | 188 | 237 | 321 | | Earnings Before Interest And Taxes | (2,593) | 431 | (666) | 2,275 | | Interest Expense | 12 | 35 | 37 | 36 | | Income Before Tax | (2,605) | 396 | (703) | 2,239 | | Income Tax Expense | (48) | 90 | 110 | 255 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,557) | 306 | (813) | 1,984 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,557) | 306 | (813) | 1,984 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,557) | $306 | ($813) | $1,984 |
|
0.08% Nasdaq 
Income Statement
